Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 84, Issue 3, 2009, Pages 201-204

  Yaghmaei, Minoo ^a   Hashemi, Mohammad ^a,b   Shikhzadeh, Abdolsamad ^b   Mokhtari, Mojgan ^a   Niazi, Abbasali ^a   Ghavami, Saeid ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alpha 1 anitrypsin; Gestational diabetes mellitus; Trypsin inhibitory capacity

Indexed keywords

ALPHA 1 ANTITRYPSIN; GLUCOSE; METHIONINE; TRYPSIN INHIBITOR;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; OXIDATION; PREGNANCY; PREGNANCY DIABETES MELLITUS;

ALPHA 1-ANTITRYPSIN; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; PREGNANCY; REFERENCE VALUES; TRYPSIN INHIBITORS;

EID: 67349122300     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.03.003     Document Type: Article

References (25)

1. Ghavami S., Hashemi M., de Serres F.J., Bajestani S.N., Mehrabifar H., and Leonardi A. Trypsin inhibitory capacity in vernal keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 48 (2007) 264-269
2. Ghavami S., Hashemi M., Shahriari H.A., Bajestani S.N., de Serres F.J., Moghaddam E., et al. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran. Clin. Biochem. 38 (2005) 425-432
3. Hashemi M., Alavian S.M., Ghavami S., de Serres F.J., Salehi M., Doroudi T., et al. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol. Res. 33 (2005) 292-297
4. Hashemi M., Naderi M., Rashidi H., and Ghavami S. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus. Diabetes Res. Clin. Pract. 75 (2007) 246-248
5. Ueda M., Mashiba S., and Uchida K. Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative alpha1-AT monoclonal antibody. Clin. Chim. Acta 317 (2002) 125-131
6. Lisowska-Myjak B., and Pachecka J. Antigenic and functional levels of alpha-1-antitrypsin in serum during normal and diabetic pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 106 (2003) 31-35
7. Dietz A.A., Rubinstein H.M., and Hodges L.K. Measurement of alpha 1 antitrypsin in serum, by immunodiffusion and enzymatic assay. Clin. Chem. Lab. Med. 20 (1974) 396-399
8. Larsson A., Palm M., Hansson L.O., Basu S., and Axelsson O. Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet. Gynecol. Scand. 87 (2008) 1084-1088
9. Kvasnicka J., Bendl J., Zivny J., Umlaufova A., and Maslowska H. Changes in hemostasis and fibrinolysis in gestational diabetes. Cas. Lek. Cesk. 135 (1996) 106-110
10. Lisowska-Myjak B., Sygitowicz G., Wolf B., and Pachecka J. Serum alpha-1-antitrypsin concentration during normal and diabetic pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 99 (2001) 53-56
11. Espana F., Gilabert J., Aznar J., Estelles A., Kobayashi T., and Griffin J.H. Complexes of activated protein C with alpha 1-antitrypsin in normal pregnancy and in severe preeclampsia. Am. J. Obstet. Gynecol. 164 (1991) 1310-1316
12. Ganrot P.O., and Bjerre B. Alpha-1-antitrypsin and alpha-2-macroglobulin concentration in serum during pregnancy. Acta. Obstet. Gynecol. Scand. 46 (1967) 126-137
13. Song C.S., Merkatz I.R., Rifkind A.B., Gillette P.N., and Kappas A. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Studies with a quantitative immunodiffusion method. Am. J. Obstet. Gynecol. 108 (1970) 227-231
14. Nielsen C.H., Poulsen H.K., Teisner B., Thorsen P., Hau J., and Westergaard J.G. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives. Eur. J. Obstet. Gynecol. Reprod. Biol. 51 (1993) 63-71
15. Kishore N., Rizvi V., Kishore N., and Sharma B.B. Effects of oral contraceptive on alpha I-antitrypsin activity. J. Obstet. Gynaecol. India 29 (1979) 259-260
16. Bhat A.R., Isaac V., and Pattabiraman T.N. Protease inhibitors in serum and amniotic fluid during pregnancy. Br. J. Obstet. Gynaecol. 86 (1979) 222-227
17. Peuchant E., Brun J.L., Rigalleau V., Dubourg L., Thomas M.J., Daniel J.Y., et al. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin. Biochem. 37 (2004) 293-298
18. Chen X., and Scholl T.O. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr. Diab. Rep. 5 (2005) 282-288
19. Chaudhari L., Tandon O.P., Vaney N., and Agarwal N. Lipid peroxidation and antioxidant enzymes in gestational diabetics, Indian. J. Physiol. Pharmacol. 47 (2003) 441-446
20. Biri A., Onan A., Devrim E., Babacan F., Kavutcu M., and Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 27 (2006) 327-332
21. Grissa O., Ategbo J.M., Yessoufou A., Tabka Z., Miled A., Jerbi M., et al. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl. Res. 150 (2007) 164-171
22. Carp H., and Janoff A. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro. J. Clin. Invest. 66 (1980) 987-995
23. Carp H., and Janoff A. Inactivation of bronchial mucous proteinase inhibitor by cigarette smoke and phagocyte-derived oxidants. Exp. Lung Res. 1 (1980) 225-237
24. Matheson N.R., Wong P.S., and Travis J. Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem. Biophys. Res. Commun. 88 (1979) 402-409
25. Swaim M.W., and Pizzo S.V. Methionine sulfoxide and the oxidative regulation of plasma proteinase inhibitors. J. Leukoc. Biol. 43 (1988) 365-379